Search - tctmd.com

Displaying 81 - 95 of 95

Sort: Relevancy | Date

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

Diet Draw: No Weight Loss Differences Between Low-Carb, Low-Fat Approaches in DIETFITS

Leah Lawrence

February 22, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

Michael O'Riordan

January 18, 2018

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Daily News

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Michael O'Riordan

April 14, 2017

News Daily News

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Alison Palkhivala

April 11, 2017

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Daily News

Money? Gadgets? Incentivizing Healthy Behaviors Questioned Once Again

Yael L. Maxwell

October 10, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

Advertisement

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Diet Draw: No Weight Loss Differences Between Low-Carb, Low-Fat Approaches in DIETFITS

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Money? Gadgets? Incentivizing Healthy Behaviors Questioned Once Again

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content